PRIMARY STUDY

Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?

Key Findings:  One of the key findings suggest that FAAH inhibitors and CBD can reduce cannabis use.

Type of Study:  Meta-analysis

Study Result:  Positive

Research Location(s):  Denmark, United Kingdom, United States

Year of Pub:  2022


Cannabinoids Studied:  Cannabidiol (CBD), Anandamide (AEA), Fatty Acid Amide Hydrolase (FAAH)

Phytocannabinoid Source:  Unspecified

Chemotype:  Chemotype III




Citation:  Rømer Thomsen K, et al. Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?. Neurosci Biobehav Rev. 2022; 132:169-180. doi: 10.1016/j.neubiorev.2021.11.033

Authors:  Rømer Thomsen K, Thylstrup B, Kenyon EA, Lees R, Baandrup L, Feldstein Ewing SW, Freeman TP